Interferons and cancer therapy

1 November 1983

journal article
review article
Published by Wiley in The Journal of Pathology

Vol. 141 (3) , 287-295
https://doi.org/10.1002/path.1711410308

Abstract

A variety of human interferons, alpha, beta and gamma are now recognised. Three types of alpha-interferon have been submitted to clinical assessment. Overall, the results have been disappointing. Attention is now directed towards their use in combination with conventional cytotoxic agents.

Keywords

This publication has 14 references indexed in Scilit:

Preliminary Observations on the Effect of Recombinant Leukocyte a Interferon in Homosexual Men with Kaposi's Sarcoma
New England Journal of Medicine, 1983
Neurological effects of recombinant human interferon.
BMJ, 1983
The present status of clinical studies with interferons in cancer in Britain
Philosophical Transactions of the Royal Society of London. B, Biological Sciences, 1982
Interferon Therapy in Juvenile Laryngeal Papillomatosis
JAMA Otolaryngology–Head & Neck Surgery, 1981
Toxicity of interferon.
BMJ, 1981
Leukocyte Interferon-Induced Tumor Regression in Human Metastatic Breast Cancer, Multiple Myeloma, and Malignant Lymphoma
Annals of Internal Medicine, 1980
INITIAL EVALUATION OF HUMAN LYMPHOBLASTOID INTERFERON IN PATIENTS WITH ADVANCED MALIGNANT DISEASE
The Lancet, 1980
Interferon: An anti-cancer agent?
Cancer Treatment Reviews, 1979
INTERFERON THERAPY IN MYELOMATOSIS
The Lancet, 1979
Mechanism of the Antitumour Effect of Interferon in Mice
Nature, 1972